Fitbit and DNA test team up to fight diabetes in At-Risk asians
NCT ID NCT05524909
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether telling overweight East Asians their genetic risk for type 2 diabetes, combined with using a Fitbit, could encourage them to be more active. 355 participants aged 40-60 were split into groups: some got just a Fitbit, others got their genetic risk plus lifestyle advice, and a third group got the genetic risk plus Fitbit's goal-setting features. The goal was to see if these tools could boost physical activity and help prevent diabetes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Genetic risk estimate and Fitbit device
- What this could lead to
- If successful, this approach could point toward a simple, scalable way to motivate lifestyle changes that help prevent type 2 diabetes in high-risk populations.
- What could go wrong
- This is a completed early-stage study focused on behavior change, not a direct treatment. The results may not lead to lasting health improvements or apply to other groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXERCISE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Exercise Physiology Lab, The University of Hong Kong
Hong Kong, Hong Kong
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Daily pill could offer new hope for weight loss in east asian adults
- Water workouts could be the key to back pain relief
- Blood test could predict who faces rapid kidney decline in diabetes
- Blood test may predict kidney decline in diabetes — a large trial investigates
- Hormone clue may unmask kidney danger in diabetes
- Can a single pill tackle both fatty liver and diabetes?